MetLife (MET) Stock: Buy, Sell, or Hold?
$102.55
+0.11 (+0.11%)
▲
5d:
-0.33%
30d:
+1.89%
90d:
+5.21%
QUANTITATIVE VERDICT
BUY
MODERATE Confidence (57%)
Quality Score
53/100
Position
EXTENDED
30-Day Fair Range
$98.32 – $101.90
Position: EXTENDED
Forward P/E & Valuation
9.2x
STRETCHED
vs 7.9x historical avg
Wall Street Target
$108.88
+6.3% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$97.78 / $106.72
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
💡 BUY OPPORTUNITY: MET shows positive signals but monitor for confirmation. Market pricing in 5.2% annual growth which appears achievable. Moderate conviction.
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Nov 5, 2026 at $99.01 · last confirmed Nov 10, 2026
Strength: 7.0/10
Get Alerted When MET Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$121.29
Based on 6.6% avg growth
INTRINSIC VALUE TODAY
$75.31
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MET is currently trading at $102.55, which is considered extended relative to its 30-day fair value range of $98.32 to $101.90. From a valuation perspective, the stock is trading at a premium (Forward PE: 9.2) compared to its historical average (7.9). At these levels, the market is pricing in 5.2% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MET is in a strong uptrend. Immediate support is located at $97.78, while resistance sits at $106.72.
Market Sentiment: MET scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MET is in a strong uptrend. Immediate support is located at $97.78, while resistance sits at $106.72.
Market Sentiment: MET scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$98.32 -
$101.90
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
Trading Range & Key Levels
30-Day Trading Range
$98.32 -
$101.90
Current vs Trading Range
EXTENDED
Support Level
$97.78
Resistance Level
$106.72
Current Trend
Strong Uptrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (63/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($108.88)
- NEUTRAL: PE elevated vs history but 5.2% growth expectation is conservative given 201% recent growth
- BULLISH: Bottoming setup score 63/100 — corrected, stabilizing, and turning up
Fundamental Context
Forward P/E (Next Year Est.)
9.18
Wall Street Target
$108.88
(+6.3%)
Revenue Growth (YoY)
18.2%
Earnings Growth (YoY)
200.8%
Profit Margin
6.2%
Valuation Premium vs History
+5.2% premium
PE vs Historical
9.2 vs 7.9
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.2%
(market-implied from PE analysis)
1-Year Target
$107.77
(+5%)
2-Year Target
$113.37
(+11%)
3-Year Target
$119.27
(+16%)
3-Yr Target (if PE normalizes)
(PE: 9→8)
PE COMPRESSION
$102.66
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 9.2%)
$288.61
(+182%)
Base:
(SPY PE: 9.2, Growth: 9.2%)
$133.38
(+30%)
Bear:
(PE: 7.8, Growth: 9.2%)
$113.37
(+11%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (13x PE), but valuation improves significantly next year (9x PE) as earnings recover.
Trailing PE: 13.29 | Current EPS (TTM): $7.65
Bull Case
$163.18
(+59%)
Analyst growth 45.9%, PE expands to 14.6
Base Case
$148.34
(+45%)
Market implied 45.9%, PE stable at 13.3
Bear Case
$69.14
(-33%)
Severe decline -20.0%, PE contracts to 11.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share MET Analysis
Share this live MET analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (MET)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 6, 2026
Daily AI digest
AI Retail Discussion Summary:
MetLife reported record performance in Q3 2026, driven by private equity gains, expense discipline, and top-line growth across all segments. Adjusted earnings per share increased by 22% year-over-year.
Key Retail Themes:
record performance
private equity gains
expense discipline
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 11:36 AM ET
Data refreshes hourly during market hours. Next update: 12:36 PM
Data refreshes hourly during market hours. Next update: 12:36 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MET showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Insurance - Life Stocks
Top-rated stocks in Insurance - Life by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
UNM
Unum Group |
BUY
13 analysts |
$99 | 55 HOLD |
|
MFC
Manulife Financial Corp |
BUY
15 analysts |
$35 | 52 HOLD |
|
GL
Globe Life Inc |
BUY
11 analysts |
$185 | 54 HOLD |
|
LNC
Lincoln National Corpora… |
HOLD
13 analysts |
$48 | 60 HOLD |
|
ABL
Abacus Life Inc. |
STRONG BUY
5 analysts |
$14 | 42 HOLD |
Advanced MET Option Strategies
Professional options setups generated by AI based on today's MET price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive MET Research Pages
